IFI-C · Eucalyptol
Specimen SS-F-CLB-301 // COOL BURN · IFI-C
Eucalyptol III-PR-A
Eucalyptus globulus
Eucalyptus
Tier IIIEucalyptol
Target Trait
2.1×
fold-change
1,8-cineole accumulation fold-change
Technical Specifications
SKU
SS-F-CLB-301
Genomic Edits
5
GC Content
45.1%
Construct Length
3,110 bp
Promoter System
Ubiquitin / T7
Expression System
Protoplast PEG-fusion
Host Strain
PEG-mediated
Receptor Target
TRPM8
IFI Score
210
Pathway Edits
- TPS-cin (1,8-cineole terpene synthase) codon-optimized overexpression cassette
- GPPS2 (geranyl pyrophosphate synthase 2) upregulation for monoterpene precursor flux
- CYP76F (cytochrome P450 76F subfamily) suppression to reduce competing hydroxylation
- MCT (methylerythritol phosphate cytidylyltransferase) MEP pathway amplification
Key Interventions
1,8-cineole overproduction via TPS-cin/GPPS2 co-upregulation in Eucalyptus globulusTRPM8 weak-agonist/TRPA1-antagonist dual mechanism via eucalyptol elevationCYP76F suppression to redirect flux toward 1,8-cineole rather than competing oxygenates
IFI Subscale Profile
IFI Profile
IFI-S—
IFI-U—
IFI-B—
IFI-K—
IFI-C210
IFI-P—
IFI-A—
IFI-F—
Use Case
Premium eucalyptus oil ingredient supply, pharmaceutical-grade 1,8-cineole production, functional food cooling ingredient development, and TRPA1-modulating flavor systems.
License
$1499 · Tier III License
Includes full construct sequence, CRISPR guide designs, pathway edit specifications, flux balance analysis, and IFI validation data.
Already purchased?